Results 11 to 20 of about 105,256 (302)

How to Diagnose Sarcopenia in Korean Older Adults?

Annals of Geriatric Medicine and Research, 2018
In 2017, Korea became an aged society, with the percentage of the population aged ≥65 years accounting for 14% of the total Korean population. The increasing number of older adults and the current health status of Korean older adults had led to increased
Hak Chul Jang, the Sarcopenia Study Group of Korean Geriatrics Society   +1 more
doaj   +2 more sources

Sarcopenia and Sarcopenic Obesity in Postmenopausal Women: Limitations of BMI as a Predictor of Sarcopenic Obesity. [PDF]

Aging Med (Milton)
The prevalence of sarcopenia and sarcopenic obesity is large among community‐dwelling postmenopausal women, and lower body mass index is a significant predictor of both. The finding that low body mass index predicts both sarcopenia and sarcopenic obesity, highlights the limitation of body mass index as a measure of adiposity in the assessment of ...
Rajan R, Cherian K, Paul T, Asha HS, Jose A, Rebekah G, Thomas N, Kapoor N.   +7 more
europepmc   +2 more sources

Sarcopenia [PDF]

Best Practice & Research Clinical Rheumatology, 2017
Sarcopenia is a condition that is characterized by loss of muscle mass, muscle strength and muscle functional impairment with ageing. The definition of sarcopenia has been through various permutations; however, an enormous recent breakthrough is the inclusion of the condition in the ICD-10 classification of diseases.
Fuggle, N., Shaw, Sarah, Dennison, Elaine, Cooper, Cyrus   +3 more
openaire   +5 more sources

Sarcopenia [PDF]

Clinical Medicine, 2014
Sarcopenia, the loss of muscle mass and function with age, is highly relevant to clinical practice as it has been associated with a wide range of ageing outcomes including disability and shorter survival times. As such it is now a major focus for research and drug discovery. There has been recent progress in the development of consensus definitions for
Alfonso J, Cruz-Jentoft, Francesco, Landi   +1 more
openaire   +8 more sources

Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. [PDF]

, 2012
Sarcopenia, the age-related skeletal muscle decline, is associated with relevant clinical and socioeconomic negative outcomes in older persons. The study of this phenomenon and the development of preventive/therapeutic strategies represent public health ...
VAN KAN G.A., AUBERTIN LEHEUDRE M., SIEBER C.C., ROUBENOFF R., VRIJBLOED J.W., INTERNATIONAL WORKING GROUP ON SARCOPENIA, ANKER S.D., PAHOR M., ZAMBONI, Mauro, FIELDING R.A., CEDARBAUM J.M., GOODPASTER B., EVANS W.J., ISAAC M., LAURENT D., CESARI M., MORLEY J.E., ROLLAND Y., VELLAS B., HELLERSTEIN M., RUTKOVER S.D., M'RINI C.   +21 more
core   +5 more sources

Sarcopenia [PDF]

Joint Bone Spine, 2019
Sarcopenia is defined as a combination of low muscle mass with low muscle function. The term was first used to designate the loss of muscle mass and performance associated with aging. Now, recognized causes of sarcopenia also include chronic disease, a physically inactive lifestyle, loss of mobility, and malnutrition.
Tournadre, Anne, Vial, Gaëlle, Capel, Frédéric, Soubrier, Martin, Boirie, Yves   +4 more
openaire   +7 more sources

The impact of sarcopenia on short-term and long-term mortality in patients with septic shock [PDF]

, 2022
Background: Despite medical advances, septic shock remains one of the main causes of high mortality in critically ill patients. Although sarcopenia is considered a predictor of mortality in septic shock patients, most studies have only investigated short-
송영구, 김정호, 정수진, 안진영, 염준섭, 최준용, 구남수   +6 more
core   +1 more source

Sarcopenia [PDF]

Nature Reviews Disease Primers
Sarcopenia is the accelerated loss of skeletal muscle mass and function commonly, but not exclusively, associated with advancing age. It is observed across many species including humans in whom it can lead to decline in physical function and mobility as well as to increased risk of adverse outcomes including falls, fractures and premature mortality ...
Avan A. Sayer, Rachel Cooper, Hidenori Arai, Peggy M. Cawthon, Marie-Josiane Ntsama Essomba, Roger A. Fielding, Miranda D. Grounds, Miles D. Witham, Alfonso J. Cruz-Jentoft   +8 more
openaire   +6 more sources

Uremic sarcopenia

Indian Journal of Nephrology, 2022
"Uremic sarcopenia" refers to a progressive decrease in muscle mass, strength, and function despite normal skeletal muscle physiology in patients with chronic kidney disease (CKD). Sarcopenia involves multiple risk factors, comprising immunological changes, hormonal, metabolic acidosis, reduced protein intake, and physical inactivity.
Mohanasundaram, Subashri, Fernando, Edwin   +1 more
openaire   +2 more sources

Different definition of sarcopenia and mortality in cancer: A meta-analysis [PDF]

, 2021
Objectives: Sarcopenia has been an emerging theme in clinical oncology. Various definitions of sarcopenia have been proposed, but their prognostic performance have yet to be evaluated and compared.
Yip, BHK, Cheung, CL, Wong, IC-K, Cheung, BMY, Li, H-L, Cheng, KK-Y, Lee, GKY, Au, PC-M, Li, HL, Chan, M, Cheng, KKY, Au, PCM, Li, GHY, Lee, GK-Y, Cheung, C-L, Wu, C-H, Wu, CH, Yip, BH-K, Lee, VHF, Lee, VH-F, Cheung, BM-Y, Wang, ICK, Wong, ICK, Li, GH-Y, Mok, J, Grace Koon-Yee Lee, Ian Chi-Kei Wong, Philip Chun-Ming Au, Benjamin Hon-Kei Yip, Marcus Chan, Hang-Long Li, Bernard Man-Yung Cheung, James Mok, Ching-Lung Cheung, Kenneth King-Yip Cheng, Gloria Hoi-Yee Li, Chih-Hsing Wu, Victor Ho-Fun Lee   +37 more
core   +1 more source